STOCK TITAN

TRANSCAT INC SEC Filings

TRNS NASDAQ

Welcome to our dedicated page for TRANSCAT SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRANSCAT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRANSCAT's regulatory disclosures and financial reporting.

Rhea-AI Summary

Conestoga Capital Advisors filed Amendment No. 5 to a Schedule 13G reporting its beneficial ownership of Transcat Inc. common stock. Conestoga Capital Advisors reports beneficial ownership of 1,013,365 shares, representing 10.86% of the outstanding common stock, with sole voting power over 943,437 shares and sole dispositive power over 1,013,365 shares. CONESTOGA FUNDS reports beneficial ownership of 626,699 shares, or 6.72% of the class, with sole voting and dispositive power over those shares. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Transcat Inc.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Transcat Inc. Chief Operating Officer Michael W. West reported an equity award of 12,028 restricted stock units (RSUs) on January 6, 2026. The RSUs were granted under the Transcat, Inc. 2021 Stock Incentive Plan at a stated price of $0 and will vest on January 6, 2028, converting into common stock on a one-for-one basis.

In addition to this new grant, West holds other RSU awards covering 1,286, 2,000, 916, 1,000 and 725 shares with vesting dates in 2026, 2027 and 2028, all on a direct ownership basis. He also directly owns 25,479 shares of Transcat common stock following the reported transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
insider
-
Rhea-AI Summary

Transcat, Inc. Chief Information Officer Michael Jacques Haddad reported an equity award of restricted stock units. On January 6, 2026, he received 5,190 restricted stock units (RSUs) at a price of $0 per unit under the Transcat, Inc. 2021 Stock Incentive Plan in a transaction exempt under Rule 16b-3. These RSUs convert into common stock on a one-for-one basis and, except as otherwise provided in the award notice, vest on January 6, 2028.

The filing also shows existing RSU holdings of 1,017 units that vest on March 25, 2028 and 730 units that vest on March 27, 2027, all reported as directly owned. Together, these awards outline a multi-year, time-based stock incentive structure for the company’s Chief Information Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
insider
Rhea-AI Summary

Transcat, Inc. reported an equity award for senior management. Sr. VP of Human Resources Theresa A. Conroy received 10,380 restricted stock units (RSUs) on January 6, 2026, which convert into common stock on a one-for-one basis and, under the 2021 Stock Incentive Plan, generally vest on January 6, 2028. The filing also lists previously granted RSUs totaling 1,098, 783, and 2,024 units that vest on March 25, 2028, March 27, 2027, and March 28, 2026, respectively. In addition, Conroy holds a fully exercisable stock option for 2,000 shares at an exercise price of $63.17 per share and directly owns 836 shares of Transcat common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
insider
-
Rhea-AI Summary

Transcat Inc reported an equity award for its Sr. VP Finance & CFO, Thomas L. Barbato. On January 6, 2026, he received 19,772 restricted stock units (RSUs), which convert into common stock on a one-for-one basis and, under the 2021 Stock Incentive Plan, are scheduled to vest on January 6, 2028, subject to the award notice.

After this grant, he directly holds these 19,772 RSUs plus additional RSU holdings of 2,691, 1,919, and 3,686 units with vesting dates in 2026–2028. He also holds stock options for 6,000 shares at $90.92 per share expiring on January 3, 2027 and 5,000 shares at $63.17 per share expiring on May 25, 2027, both reported as directly owned. In addition, he directly owns 1,699 shares of Transcat common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
insider
-
Rhea-AI Summary

Transcat, Inc. disclosed that its Compensation Committee approved a special one-time equity retention package for four executive officers under the 2021 Stock Incentive Plan. The awards are in the form of restricted stock units, with grants of 19,772 RSUs to Thomas L. Barbato, 10,380 to Theresa A. Conroy, 5,190 to Michael J. Haddad, and 12,028 to Michael W. West.

The retention awards are scheduled to vest on January 6, 2028, conditioned on each executive’s continued employment and as otherwise detailed in the award agreements. The company explains that these awards are intended to preserve leadership continuity during the transition to a successor chief executive officer and to directly incentivize the executives’ ongoing contributions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.03%
Tags
current report
Rhea-AI Summary

Transcat, Inc. reported Q2 FY2026 results with total revenue of $82.3 million, up 21.3% year over year. Service revenue was $52.8 million and Distribution revenue was $29.4 million. Gross profit rose to $26.8 million with a total gross margin of 32.5%.

Operating income was $3.5 million as operating expenses increased with acquisitions and higher compensation. Net income was $1.3 million and diluted EPS was $0.14. Interest and other expense increased to $1.5 million, reflecting higher borrowings.

For the first six months, revenue reached $158.7 million and net income was $4.5 million. Operating cash flow was $16.5 million, while investing cash flow used $91.6 million, primarily for acquisitions. The company closed a new five‑year $150.0 million secured revolving credit facility; $111.9 million was outstanding as of September 27, 2025. Transcat acquired Essco for approximately $85.6 million and earlier acquired Martin for approximately $81.8 million. Total assets were $484.9 million, long‑term debt was $111.9 million, and shares outstanding were 9,328,412 as of October 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Filing
Rhea-AI Summary

Transcat, Inc. (TRNS) announced fiscal 2026 second‑quarter results for the period ended September 27, 2025, via a press release furnished as Exhibit 99.1. The company also posted investor presentation slides (Exhibit 99.2) on its website to accompany an earnings conference call and webcast scheduled for 4:30 p.m. Eastern Time on November 3, 2025.

The materials are furnished under Item 2.02 and are not deemed filed under the Securities Exchange Act of 1934.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.71%
Tags
current report
-
Rhea-AI Summary

Robert Mecca, a director of Transcat Inc. (TRNS), reported equity award activity on 09/10/2025 and 09/11/2025. On 09/10/2025 the filing shows restricted stock units (RSUs) granted totaling 1,587 RSUs that convert one-for-one into common stock and, per the award terms, generally vest on September 10, 2026. On 09/11/2025 a separate tranche of 704 RSUs is reported as vested, converting into common stock. The filing also discloses a stock option covering 10,000 shares with an exercise price of $98.88 and an expiration date of January 24, 2034; this option vests pro rata over five years. The form is signed by an attorney-in-fact on behalf of Mr. Mecca on September 11, 2025. The disclosure is limited to these award and vesting events and does not include earnings, cash transactions, or other operational details.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Transcat Inc. (TRNS) director Mbago M. Kaniki received equity awards and holds an option position. The filing reports conversion-eligible restricted stock units (RSUs) that convert one-for-one into common stock. RSUs granted 09/10/2025 total 1,587 shares and vest on 09/10/2026. An additional 704 RSUs vested and converted on 09/11/2025, increasing beneficial ownership by 704 shares. The reporting person also holds a stock option to buy 10,000 shares at $47.14 per share exercisable on a pro rata vesting schedule through 05/12/2031. After the reported transactions, the filer directly beneficially owns 2,593 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many TRANSCAT (TRNS) SEC filings are available on StockTitan?

StockTitan tracks 58 SEC filings for TRANSCAT (TRNS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TRANSCAT (TRNS)?

The most recent SEC filing for TRANSCAT (TRNS) was filed on January 9, 2026.